**Presentations linked below are those whose presenters granted permission for posting.**

 

Community Working Group Plenary  

Sunday, 12 June 2016

AMP CRS Real World Experience: Americas	Dashawn Usher
AMP CRS Real World Experience: Zimbabwe	Zvichauya Charles Chasakara
Engaging and Recruiting Black MSM (BMSM) in the US	Noshima Darden-Tabb
Community Engagement in a Large Community Randomised Trial: The Case of the HPTN 071 (PopART) Study	Nozizwe Makola, Steve Bulemu and Musonda Simwinga
Engaging PWIDs in a Research Study: HPTN 074 Vietnam	Chu Viet Anh
HPTN 075 Study Overview & External Stakeholder Engagement	Daniel K. Gondwe
Overview of HPTN 075 & Best Practices for Community Engagement with External Stakeholders	Joshua M. Kikuvi
Best Practices for Community Engagement with External Stakeholders: HPTN 075 study	Arthur Ogendo
Community Acceptability of Injections: Experience from HPTN 077	Steve Mphonda
HIV Prevention Trials Network Community Working Group Plenary: Lessons Learned in HPTN 077	Fanelesibonge Ntombela
HPTN 082 and PrEP Research in Africa	Sinead Delany-Moretlwe
Injectable Pre-Exposure Prophylaxis for HIV Prevention	Raphael J. Landovitz,
Antibody Mediated HIV Prevention: An Overview	Nyaradzo M Mgodi

 

 

Lab Plenary 

Tuesday, 14 June 2016

HIV Testing Update	Estelle Pinowar-Manning
Population-level Surveillance of Antiretroviral Drug Use	Jessica Fogel
Cross-sectional HCV Incidence Testing	Oliver Laeyendecker

Scholars Plenary 

Tuesday, 14 June 2016

Factors Associated with Recent HIV Testing in Project Accept Sub-Populations: HPTN 043	Brandon Brown
Community Cultural Norms and Condomless Sexual Behavior Among Men Living with HIV Across Three Continents: HPTN 063	Dustin Duncan
Associations between gender, race, and HIV risk among injection drug users: A secondary analysis of HPTN 037	Mandy Hill
Racial Disparities in HIV Prevalence and Composition of Risk Networks among People who Inject Drugs: HPTN 037	Florence Momplaisir
HIV Transmission Risk Among Transgender Women compared with Cisgender Women and MSM Living with HIV: HPTN 063	Tonia Poteat
Economic resources and HIV preventive behaviors among school-enrolled young women in rural South Africa: HPTN 068	Larissa Jennings

Modelling Plenary 

Tuesday, 14 June 2016

Introducing HPTN Modelling Centre Who? What? When? How?	Marie-Claude Boily
Modelling HIV Transmission and Treatment for US MSM to Estimate the Impact of HPTN 078 on HIV Incidence	Kate Mitchell
Predicting the individual-level effectiveness of daily and nondaily PrEP based on study results from HPTN 067 ADAPT	Dobromir Dimitrov

Statistical Plenary 

Tuesday, 14 June 2016

Methods for Estimating Underreporting of Risk Behaviors	Jim Hughes
Designing Non-Inferiority Trials when the Noninferiority Margin Depends on Adherence – HPTN 083	Brett Hanscom
Combining Electronic Pill Records and Self-Reported Data to Identify Adherers and Non-Adherers - A Latent Class Model in HPTN 069	Ying Qing Chen

PrEP Plenary 

Tuesday, 14 June 2016

How Do You Like Your PrEP? Results from the HPTN 067/ADAPT Study	Robert Grant
Phase II Study of Maraviroc (MVC)-Containing Regimens for HIV PrEP in Men Who Have Sex With Men (MSM)	Roy Gulick
Uptake and Utilization of PrEP Among Black MSM: Why Race Matters (HPTN 073)	Darrell Wheeler
Cabotegravir as Pre-Exposure Prophylaxis for HIV Prevention	Raphael Landovitz
Antibody Mediated HIV Prevention The AMP Studies	Nyaradzo Mgodi

Joint Plenary 

Wednesday, 15 June 2016

NIAID: State of the Institute and Priorities in HIV/AIDS Research	Anthony Fauci
HPTN State of the Network: Achievements and Way Forward	Wafaa El-Sadr
Optimizing Treatment for Children and Adolescents: The Power of NOW	Martina Penazzato
Sex and secrecy: Disclosure to intimate partners among YPLWH	Linda-Gail Bekker
HIV in Transgender Populations: Evidence for Action	Tonia Poteat
Male involvement in HIV Prevention Trials: Examples from HPTN071	Helen Ayles